![Frontiers | Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task Frontiers | Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task](https://www.frontiersin.org/files/Articles/840971/fendo-13-840971-HTML-r1/image_m/fendo-13-840971-g001.jpg)
Frontiers | Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
Adverse Reactions From Three Polled Placebo-Controlled Clinical Studies With STEGLATRO® (Ertugliflozin)
![The Risk Factors for Asymptomatic Pyuria Among Patients With Type 2 Diabetes | Waragai | Journal of Endocrinology and Metabolism The Risk Factors for Asymptomatic Pyuria Among Patients With Type 2 Diabetes | Waragai | Journal of Endocrinology and Metabolism](https://www.jofem.org/tables/jem629-g001.jpg)
The Risk Factors for Asymptomatic Pyuria Among Patients With Type 2 Diabetes | Waragai | Journal of Endocrinology and Metabolism
![Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus - The Lancet Diabetes & Endocrinology Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/29c8e347-c783-4ff7-ab20-b158fa165a5f/gr1_lrg.jpg)